About: covid:e2da25879ef605f8c5d598a47db610eb36aefe22

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:e2da25879ef605f8c5d598a47db610eb36aefe22 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Zheng, Wei Chen, Lu Muratov, Eugene Guo, Hui Shinn, Paul Simeonov, Anton Hall, Matthew Chen, Catherine Eastman, Richard Itkin, Zina Michael, Sam Bobrowski, Tesia Hall, Beard Zakharov, Alexey
is schema:about of	named entity 'strong' named entity 'Overall' named entity 'current' named entity 'SARS-CoV-2' named entity 'FDA' named entity 'preclinical' named entity 'mechanisms' named entity 'synergy' named entity 'AMODIAQUINE' named entity 'strong' named entity 'potential' named entity 'infections' named entity 'combination' named entity 'vaccine' named entity 'disease' named entity 'potential' named entity 'SARS-CoV-2' named entity 'Drug' named entity 'approved drug' named entity 'synergistic interaction' named entity 'remdesivir' named entity 'dose-dependent manner' named entity 'viral disease' named entity 'amodiaquine' named entity 'Synergistic' named entity 'lysosome' named entity 'preprint' named entity 'heme detoxification' named entity 'doi' named entity 'remdesivir' named entity 'kinase' named entity '2.0' named entity 'amodiaquine' named entity 'remdesivir' named entity 'non-toxic' named entity 'Vero E6' named entity 'peer review' named entity 'remdesivir' named entity 'preprint' named entity 'viral entry' named entity 'amodiaquine' named entity 'hydrolyzed' named entity 'preprint' named entity 'proteases' named entity 'doi' named entity 'tertiary amine' named entity 'preprint' named entity 'replication of viruses' named entity 'preprint' named entity 'hepatitis C virus' named entity 'umifenovir' named entity 'amodiaquine' named entity 'antiviral' named entity 'CC-BY 4.0 International license' named entity 'nitazoxanide' named entity 'SARS-CoV-2' named entity 'NCATS' named entity 'doi' named entity 'GSK-3β' named entity 'protein kinase' named entity 'preprint' named entity 'bioRxiv' named entity 'preprint' named entity 'camostat' named entity 'parasite' named entity 'preprint' named entity 'kinase' named entity 'FDA' named entity 'protein tyrosine kinase' named entity 'CC-BY 4.0 International license' named entity 'bioRxiv' named entity 'umifenovir' named entity 'umifenovir' named entity 'bioRxiv' named entity 'bioRxiv' named entity 'mechanism of action' named entity 'preprint' named entity 'CC-BY 4.0 International license' named entity 'doi' named entity 'HSA' named entity 'amodiaquine' named entity 'antivirals' named entity 'CC-BY 4.0 International license' named entity 'preprint' named entity 'cytotoxicity assay' named entity 'randomized trial'

Attributes

Values

Creator

Zheng, Wei
Chen, Lu
Muratov, Eugene
Guo, Hui
Shinn, Paul
Simeonov, Anton
Hall, Matthew
Chen, Catherine
Eastman, Richard
Itkin, Zina
Michael, Sam
Bobrowski, Tesia
Hall, Beard
Zakharov, Alexey

is schema:about of

named entity 'strong'
named entity 'Overall'
named entity 'current'
named entity 'SARS-CoV-2'
named entity 'FDA'
named entity 'preclinical'
named entity 'mechanisms'
named entity 'synergy'
named entity 'AMODIAQUINE'
named entity 'strong'
named entity 'potential'
named entity 'infections'
named entity 'combination'
named entity 'vaccine'
named entity 'disease'
named entity 'potential'
named entity 'SARS-CoV-2'
named entity 'Drug'
named entity 'approved drug'
named entity 'synergistic interaction'
named entity 'remdesivir'
named entity 'dose-dependent manner'
named entity 'viral disease'
named entity 'amodiaquine'
named entity 'Synergistic'
named entity 'lysosome'
named entity 'preprint'
named entity 'heme detoxification'
named entity 'doi'
named entity 'remdesivir'
named entity 'kinase'
named entity '2.0'
named entity 'amodiaquine'
named entity 'remdesivir'
named entity 'non-toxic'
named entity 'Vero E6'
named entity 'peer review'
named entity 'remdesivir'
named entity 'preprint'
named entity 'viral entry'
named entity 'amodiaquine'
named entity 'hydrolyzed'
named entity 'preprint'
named entity 'proteases'
named entity 'doi'
named entity 'tertiary amine'
named entity 'preprint'
named entity 'replication of viruses'
named entity 'preprint'
named entity 'hepatitis C virus'
named entity 'umifenovir'
named entity 'amodiaquine'
named entity 'antiviral'
named entity 'CC-BY 4.0 International license'
named entity 'nitazoxanide'
named entity 'SARS-CoV-2'
named entity 'NCATS'
named entity 'doi'
named entity 'GSK-3β'
named entity 'protein kinase'
named entity 'preprint'
named entity 'bioRxiv'
named entity 'preprint'
named entity 'camostat'
named entity 'parasite'
named entity 'preprint'
named entity 'kinase'
named entity 'FDA'
named entity 'protein tyrosine kinase'
named entity 'CC-BY 4.0 International license'
named entity 'bioRxiv'
named entity 'umifenovir'
named entity 'umifenovir'
named entity 'bioRxiv'
named entity 'bioRxiv'
named entity 'mechanism of action'
named entity 'preprint'
named entity 'CC-BY 4.0 International license'
named entity 'doi'
named entity 'HSA'
named entity 'amodiaquine'
named entity 'antivirals'
named entity 'CC-BY 4.0 International license'
named entity 'preprint'
named entity 'cytotoxicity assay'
named entity 'randomized trial'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software